Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-746P (RNA, U6 small nuclear 746, pseudogene) is a human gene locus classified as a pseudogene of the U6 small nuclear RNA family. U6 snRNA is a highly conserved, functional non-coding RNA central to pre-mRNA splicing in the spliceosome[1][3]. However, pseudogenes such as RNU6-746P do not produce functional RNA and are typically the result of gene duplication, retrotransposition, or genomic rearrangements, and are generally not transcribed or translated into functional molecules[4]. RNU6-746P lacks promoter elements or coding sequence necessary for function, and is neither a gene product nor a molecular target[4]. It does not play a role in normal biological processes, disease mechanisms, or serve as a drug target. Summary of assessment: - RNU6-746P is a **pseudogene**, not a receptor, enzyme, transporter, transcription factor, or any other therapeutic target class[4]. - It has **no functional biological activity, disease association, nor drug interactions**. - The **entry is "incorrect" as a therapeutic target**; it is accurately labeled as a pseudogene, but does not meet criteria as a molecular target for drug discovery or basic biology. - Information about the **functional U6 snRNA** (not the pseudogene) can be found in sources describing its role in splicing and RNA-protein interactions[1][3]; however, this is not applicable to RNU6-746P. If you require information on the **functional U6 snRNA** (not its pseudogenes), please clarify your request.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 746, pseudogene (RNU6-746P).